The Japanese pharmaceutical market is the second largest pharma market in the world following on the close heels of the US. Although it records annual sales of approximately $64.5 billion (6.45 trillion Yen), only 6.6 percent of its prescription... Read more
Singapore: Taiwan-based TWi Pharmaceuticals has received tentative approval for its Abbreviated New Drug Application (ANDA)... Read more
Singapore: A new report by investment bank Alpen Capital titled, 'The GCC pharmaceutical Outlook', a number of Gulf Cooperation... Read more
India-headquartered Dr Reddy's Laboratories is making a strong name in biosimilars business in India and in the world. In 2011, the company... Read more
Singapore: In support of its commitment to maximize growth opportunities in China, Eli Lilly has decided to increase its network of manufacturing... Read more
The king of generics, Cipla, has been aggressive in expanding product portfolio and reaching out to international market. Without missing... Read more
The year 2011 was a year of capturing potential markets and achieving new milestones. Ranbaxy Laboratories became the first pharmaceutical... Read more
India's top drug regulatory body, the Central Drug Standard Control Organization (CDSO) is literally facing the heat, this summer. In May,... Read more
Mumbai: Lupin Pharmaceuticals, a subsidiary of India-based Lupin, has received approval for Suprax (Cefixime) Capsules 400 mg from the US... Read more
Singapore: The global generic pharmaceuticals market is likely to witness strong growth in the next few years owing to the patent expiration... Read more
Bangalore: India-based Aurobindo Pharma has received final approval from the US Food & Drug Administration for Nevirapine tablets 200mg... Read more
A rapidly aging population has burdened the healthcare system both in terms of funding and facilities and is of great concern for the Japanese... Read more
Survey Box
Subscribe to BioSpectrum Asia digital mag at an attractive price of US $49.99 a year
(Includes all 24 regular & special issues @ fortnightly frequency)
Australia
China
India
Japan
Korea
Malaysia
New Zealand 
Singapore
Taiwan
Thailand
